Experts focus discussion on FDA's role in comparative effectiveness

02/18/2010 | Medical Devices Today

The FDA's role in comparative-effectiveness research was the focus during a meeting called by a task force of the agency's device center. Diana Zuckerman, a patient advocate, suggested the FDA use comparative studies conducted by groups such as the Agency for Healthcare Research and Quality in assessing the efficacy of new and older devices. Timothy Wright, a principal scientist at a New York hospital, said he believes the agency's role is not comparative effectiveness, but public health.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX